FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $823 | -98.4% | 110 | -98.0% | 0.00% | – |
| Q2 2023 | $50,681 | -66.5% | 5,404 | -70.9% | 0.00% | – |
| Q1 2023 | $151,099 | -7.2% | 18,590 | +10.3% | 0.00% | – |
| Q4 2022 | $162,766 | +1708.5% | 16,848 | +1069.2% | 0.00% | – |
| Q1 2021 | $9,000 | -70.0% | 1,441 | -65.2% | 0.00% | – |
| Q4 2020 | $30,000 | +400.0% | 4,141 | +302.8% | 0.00% | – |
| Q3 2020 | $6,000 | -75.0% | 1,028 | -64.6% | 0.00% | – |
| Q2 2020 | $24,000 | +242.9% | 2,900 | +159.4% | 0.00% | – |
| Q1 2020 | $7,000 | +16.7% | 1,118 | -14.5% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 1,308 | -26.2% | 0.00% | – |
| Q2 2019 | $8,000 | -50.0% | 1,773 | -46.5% | 0.00% | – |
| Q1 2019 | $16,000 | -15.8% | 3,313 | +8.8% | 0.00% | – |
| Q4 2018 | $19,000 | -26.9% | 3,046 | -4.8% | 0.00% | – |
| Q3 2018 | $26,000 | +52.9% | 3,199 | +96.5% | 0.00% | – |
| Q2 2018 | $17,000 | – | 1,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $18,079,251 | 17.55% |
| Solas Capital Management, LLC | 1,725,567 | $12,959,008 | 9.07% |
| DG Capital Management, LLC | 1,143,099 | $8,584,673 | 4.70% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $3,506,186 | 2.56% |
| AIGH Capital Management LLC | 373,526 | $2,805,180 | 1.33% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,619,877 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $525,700 | 0.68% |
| Worth Venture Partners, LLC | 92,636 | $695,696 | 0.41% |
| Lion Point Capital, LP | 110,000 | $826,100 | 0.37% |
| 683 Capital Management, LLC | 300,000 | $2,253,000 | 0.18% |